JP Morgan Chase’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $583M | Sell |
|
|||||
|
2023
Q2 | $565M | Buy |
|
|||||
|
2023
Q1 | $599M | Sell |
|
|||||
|
2022
Q4 | $1.28B | Buy |
|
|||||
|
2022
Q3 | $420M | Buy |
|
|||||
|
2022
Q2 | $531M | Buy |
|
|||||
|
2022
Q1 | $644M | Buy |
|
|||||
|
2021
Q4 | $655M | Buy |
|
|||||
|
2021
Q3 | $637M | Sell |
|
|||||
|
2021
Q2 | $563M | Buy |
|
|||||
|
2021
Q1 | $519M | Sell |
|
|||||
|
2020
Q4 | $432M | Buy |
|
|||||
|
2020
Q3 | $403M | Buy |
|
|||||
|
2020
Q2 | $261M | Buy |
|
|||||
|
2020
Q1 | $122M | Buy |
|
|||||
|
2019
Q4 | $136M | Sell |
|
|||||
|
2019
Q3 | $134M | Sell |
|
|||||
|
2019
Q2 | $122M | Buy |
|
|||||
|
2019
Q1 | $117M | Sell |
|
|||||
|
2018
Q4 | $102M | Buy |
|
|||||
|
2018
Q3 | $99.1M | Sell |
|
|||||
|
2018
Q2 | $89.4M | Buy |
|
|||||
|
2018
Q1 | $50M | Sell |
|
|||||
|
2017
Q4 | $54.9M | Buy |
|
|||||
|
2017
Q3 | $43.1M | Sell |
|
|||||
|
2017
Q2 | $45.5M | Sell |
|
|||||
|
2017
Q1 | $92.7M | Sell |
|
|||||
|
2016
Q4 | $110M | Buy |
|
|||||
|
2016
Q3 | $78.3M | Sell |
|
|||||
|
2016
Q2 | $71.5M | Buy |
|
|||||
|
2016
Q1 | $56M | Buy |
|
|||||
|
2015
Q4 | $71M | Sell |
|
|||||
|
2015
Q3 | $78.5M | Buy |
|
|||||
|
2015
Q2 | $133M | Buy |
|
|||||
|
2015
Q1 | $37.8M | Buy |
|
|||||
|
2014
Q4 | $140K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $64K | Buy |
|